Upstream Bio (UPB) Other Working Capital Changes (2023 - 2026)
Upstream Bio's (UPB) quarterly Other Working Capital Changes came in at -$155000.0 in Q1 2026, down 15.67% year-on-year from -$183805.3 in Q1 2025, and down 3.33% quarter-over-quarter from -$150000.0 in Q4 2025.
Upstream Bio (UPB) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Upstream Bio's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$155000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 15.67% year-over-year to -$155000.0 in Q1 2026; TTM through Mar 2026 was -$586000.0, a 139.18% decrease from a year earlier, with the FY2025 full-year figure at -$565000.0, down 324.81% from the prior year.
- Other Working Capital Changes eased to -$155000.0 in Q1 2026 per UPB's latest filing, from -$150000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $13.7 million in Q1 2025 and bottomed at -$7.8 million in Q3 2025.
- The 4-year median for Other Working Capital Changes is $1.8 million (2024), against an average of $1.9 million.
- Across the five-year window, Other Working Capital Changes tumbled 847.37% in 2025 and decreased 15.67% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at -$20000.0 in 2023, then sank by 435.0% to -$107000.0 in 2024, then slumped by 40.19% to -$150000.0 in 2025, then retreated by 3.33% to -$155000.0 in 2026.
- Per Business Quant, the three latest UPB Other Working Capital Changes figures stand at -$155000.0 (Q1 2026), -$150000.0 (Q4 2025), and -$142000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Upstream Bio | 347.73 Mn | 347.73 Mn | -3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -155,000.00 |
| Mar 31, 2026 | -155,000.00 |
| Mar 31, 2026 | -155,000.00 |
| Dec 31, 2025 | -150,000.00 |
| Dec 31, 2025 | -150,000.00 |
| Dec 31, 2025 | -150,000.00 |
| Sep 30, 2025 | -142,000.00 |
| Sep 30, 2025 | -142,000.00 |
| Sep 30, 2025 | -142,000.00 |
| Jun 30, 2025 | -139,000.00 |
| Jun 30, 2025 | -139,000.00 |
| Jun 30, 2025 | -139,000.00 |
| Mar 31, 2025 | -134,000.00 |
| Mar 31, 2025 | -134,000.00 |
| Mar 31, 2025 | -134,000.00 |
| Dec 31, 2024 | -107,000.00 |
| Dec 31, 2024 | -107,000.00 |
| Dec 31, 2024 | -107,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Sep 30, 2024 | 19,000.00 |